Maintaining a Sterile Urinary Tract: The Role of Antimicrobial Peptides

Journal of Urology

Volumn 182, Issue 1, 2009, Pages 21-28

  Ali, Ased S M ^a   Townes, Claire L ^a   Hall, Judith ^a   Pickard, Robert S ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

antimicrobial cationic peptides; immunity; innate; urinary tract infections

Indexed keywords

ALPHA DEFENSIN; ANTIBIOTIC AGENT; BETA DEFENSIN 1; BETA DEFENSIN 2; BUTYRIC ACID; CATHELICIDIN; CECROPIN; HEPCIDIN; LACTOFERRIN B; MAGAININ DERIVATIVE; MX 226; OMIGANAN PENTAHYDROCHLORIDE; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; VITAMIN D;

ANTIMICROBIAL ACTIVITY; CATHETER INFECTION; CLINICAL TRIAL; DISEASE PREDISPOSITION; DRUG MECHANISM; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; INNATE IMMUNITY; MEDICAL LITERATURE; MORBIDITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SEX DIFFERENCE; SKIN INFECTION; URETER CATHETERIZATION; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; VITAMIN D DEFICIENCY;

ANTIMICROBIAL CATIONIC PEPTIDES; FEMALE; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; MALE; SENSITIVITY AND SPECIFICITY; TOLL-LIKE RECEPTORS; URINARY TRACT; URINARY TRACT INFECTIONS; URINARY TRACT PHYSIOLOGICAL PHENOMENA;

EID: 67349171664     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.02.124     Document Type: Review

References (49)

1. Kucheria R., Dasgupta P., Sacks S.H., Khan M.S., and Sheerin N.S. Urinary tract infections: new insights into a common problem. Postgrad Med J 81 (2005) 83
2. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113 suppl. (2002) 5S
3. Franco A.V. Recurrent urinary tract infections. Best Pract Res Clin Obstet Gynaecol 19 (2005) 861
4. Stapleton A. Prevention of recurrent urinary-tract infections in women. Lancet 353 (1999) 7
5. Zaiou M. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J Mol Med 85 (2007) 317
6. Tytler E.M., Anantharamaiah G.M., Walker D.E., Mishra V.K., Palgunachari M.N., and Segrest J.P. Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry 34 (1995) 4393
7. Ludtke S.J., He K., Heller W.T., Harroun T.A., Yang L., and Huang H.W. Membrane pores induced by magainins. Biochemistry 35 (1996) 13723
8. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1462 (1999) 55
9. Mor A. Peptide-based antibiotics: a potential answer to raging antimicrobial resistance. Drug Dev Res 50 (2000) 440
10. Wieprecht T., Dathe M., Beyermann M., Krause E., Maloy W.L., MacDonald D.L., et al. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry 36 (1997) 6124
11. Matsuzaki K., Sugislita K., Ishibe N., Ueha M., Nakata S., Miyajima K., et al. Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry 37 (1998) 11856
12. Dagan A., Efron L., Gaidukov L., Mor A., and Ginsburg H. In vitro antiplasmodium effects of dermaseptin S4 derivatives. Antimicrob Agents Chemother 46 (2002) 1059
13. Matsuzaki K., Sugishita K., Harada M., Fujii N., and Miyajima K. Interactions of an antimicrobial peptide, magainin-2, with outer and inner membranes of gram-negative bacteria. Biochim Biophys Acta 1327 (1997) 119
14. Tossi A., Sandri L., and Giangaspero A. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55 (2000) 4
15. Peschel A., and Sahl H.G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 4 (2006) 529
16. Tikhonov I., Rebenok A., and Chyzh A. A study of interleukin-8 and defensins in urine and plasma of patients with pyelonephritis and glomerulonephritis. Nephrol Dial Transplant 12 (1997) 2557
17. Bevins C.L. Paneth cell defensins: key effector molecules of innate immunity. Biochem Soc Trans 34 (2006) 263
18. Wiechula B.E., Friedek D.A., Ekiel A.M., Romanik M.K., and Martirosian G. Human neutrophil peptides in vaginitis/cervicitis of different etiology. Pol J Microbiol 56 (2007) 185
19. Quayle A.J., Porter E.M., Nussbaum A.A., Wang Y.M., Brabec C., Yip K.P., et al. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 152 (1998) 1247
20. Ali A.S.M., Townes C.L., Hall J., and Pickard R.S. Differential expression of the HD5 antimicrobial peptide in the human urinary tract. BJU Int 101 suppl. (2008) 42
21. Schutte B.C., Mitros J.P., Bartlett J.A., Walters J.D., Jia H.P., Welsh M.J., et al. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A 99 (2002) 2129
22. Leong W.I., and Lönnerdal B. Hepcidin, the recently identified peptide that appears to regulate iron absorption. J Nutr 134 (2004) 1
23. Valore E.V., Park C.H., Quayle A.J., Wiles K.R., McCray Jr. P.B., and Ganz T. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 101 (1998) 1633
24. Lehmann J., Retz M., Harder J., Krams M., Kellner U., Hartmann J., et al. Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect Dis 2 (2002) 20
25. Morrison G., Kilanowski F., Davidson D., and Dorin J. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect Immun 70 (2002) 3053
26. Fleming D.C., King A.E., Williams A.R., Critchley H.O., and Kelly R.W. Hormonal contraception can suppress natural antimicrobial gene transcription in human endometrium. Fertil Steril 79 (2003) 856
27. King A.E., Fleming D.C., Critchley H.O., and Kelly R.W. Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium. J Reprod Immunol 59 (2003) 1
28. Fellermann K., Stange D.E., Schaeffeler E., Schmalzl H., Wehkamp J., Bevins C.L., et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 79 (2006) 439
29. Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96 (2000) 3086
30. Chromek M., Slamová Z., Bergman P., Kovács L., Podracká L., Ehrén I., et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12 (2006) 636
31. Park C.H., Valore E.V., Waring A.J., and Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276 (2001) 7806
32. Krause A., Neitz S., Mägert H.J., Schulz A., Forssmann W.G., Schulz-Knappe P., et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480 (2000) 147
33. Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Wolfsdorf J.I., and Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100 (2002) 3776
34. Serafini-Cessi F., Malagolini N., and Cavallone D. Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis 42 (2003) 658
35. Bates J.M., Raffi H.M., Prasadan K., Mascarenhas R., Laszik Z., Maeda N., et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 65 (2004) 791
36. Berger T., Togawa A., Duncan G.S., Elia A.J., You-Ten A., Wakeham A., et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A 103 (2006) 1834
37. Abrink M., Larsson E., Gobl A., and Hellman L. Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism. Kidney Int 57 (2000) 2004
38. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int Immunol 17 (2005) 1
39. Hoskin D.W., and Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 1778 (2008) 357
40. www.migenix.com/prod_226.html. Accessed February 11, 2009.
41. Ballweber L.M., Jaynes J.E., Stamm W.E., and Lampe M.F. In vitro microbicidal activitites of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis. Antimicrob Agents Chemother 46 (2002) 34
42. Haversen L.A., Engberg I., Baltzer L., Dolphin G., Hanson L.A., and Mattsby-Baltzer I. Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect Immun 68 (2000) 5816
43. Zasloff M. Defending the epithelium. Nat Med 12 (2006) 607
44. Wang T.T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173 (2004) 2909
45. Schauber J., Svanholm C., Termen S., Iffland K., Menzel T., Scheppach W., et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 52 (2003) 735
46. Gombart A.F., Borregaard N., and Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25dihydroxyvitamin D3. FASEB J 19 (2005) 1067
47. Bland R., Zehnder D., Hughes S.V., Ronco P.M., Stewart P.M., and Hewison M. Regulation of vitamin D-1alpha-hydroxylase in a human cortical collecting duct cell line. Kidney Int 60 (2001) 1277
48. Raqib R., Sarker P., Bergman P., Ara G., Lindh M., Sack D.A., et al. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci U S A 103 (2006) 9178
49. Schumm K., Lam T.B., et al. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev (2008) CD004013